Sequence heterogeneity and viral dynamics in cerebrospinal fluid and plasma during antiretroviral therapy
1Department of Medicine, Division of Infectious Diseases, Vanderbilt Medical School, Nashville, Tennessee 37203, USA. david.w.haas@vanderbilt.edu
Abstract:
Understanding of human immunodeficiency virus (HIV) neuropathogenesis has been greatly enhanced by careful analyses of postmortem brain tissue, as well as by primate models of infection with related lentiviruses. However, brain tissue from persons living with HIV infection is rarely available for study, and elegant observations from primate systems may require confirmation in humans. Because of these inherent limitations, it is important to learn as much as possible by studying cerebrospinal fluid (CSF) during HIV infection. The present discussion considers selected issues relevant to the study of CSF from HIV-infected individuals. These include a strategy to intensely sample CSF to better understand viral dynamics and the role of the brain as a pharmacologic sanctuary site, evidence for HIV sequence diversity in CSF and plasma during HIV therapy and the implications of such diversity, and the importance of host genetics relevant to studying HIV neuropathogenesis.
More Related Videos
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Related Concept Videos
Retrovirus Life Cycles
Viral Mutations
Size and Structure of Viral Genomes
Inhibitors of Virion Maturation and Assembly
